R. Tierney

发表

Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals

G. Cooper, M. Rowe, A. Rickinson, 1996, Journal of virology.

Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort

A. Rickinson, F. Hill, C. Conlon, 1998, Journal of Virology.

Induction of Interferon-Stimulated Genes on the IL-4 Response Axis by Epstein-Barr Virus Infected Human B Cells; Relevance to Cellular Transformation

C. Woodman, P. Murray, M. Rowe, 2013, PloS one.

Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells

A. Strasser, M. Rowe, R. Tierney, 2017, Cell Death and Differentiation.

Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state

L. Young, A. Rickinson, N. Steven, 1994, Journal of virology.

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

M. Fitzpatrick, A. Rickinson, A. Leese, 2016, PLoS pathogens.

Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.

L. Young, G. Niedobitek, R. Tierney, 1994, The American journal of pathology.

Non‐Hodgkin's lymphoma, coeliac disease, and Epstein–Barr virus: A study of 13 cases of enteropathy‐associated T‐ and B‐cell lymphoma

M. Ilyas, L. Young, G. Niedobitek, 1995, The Journal of pathology.

Repression of the Proapoptotic Cellular BIK/NBK Gene by Epstein-Barr Virus Antagonizes Transforming Growth Factor β1-Induced B-Cell Apoptosis

P. Cahill, Roya Hakimjavadi, D. Walls, 2014, Journal of Virology.

Methylation Status of the Epstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and Lymphoblastoid Cell Lines (cid:1)

A. Rickinson, R. Tierney, G. Kelly, 2006 .

Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains

A. Rickinson, A. Leese, R. Tierney, 2000, Journal of Virology.

Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals

G. Cooper, M. Rowe, A. Rickinson, 1996, Journal of virology.

PCR for the detection of genital human papillomavirus infection: a mixed blessing.

C. Woodman, L. Young, H. Winter, 1992, Annals of medicine.

Epstein-Barr Virus BamHI W Repeat Number Limits EBNA2/EBNA-LP Coexpression in Newly Infected B Cells and the Efficiency of B-Cell Transformation: a Rationale for the Multiple W Repeats in Wild-Type Virus Strains

A. Rickinson, R. Tierney, Kuan-Yu Kao, 2011, Journal of Virology.

Growth-Transforming Program Achieve the B-Cell Specificity of Its Epstein-Barr Virus Exploits BSAP / Pax 5 To

W. Hammerschmidt, A. Rickinson, R. Tierney, 2007 .

Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix.

C. Woodman, L. Young, R. Tierney, 1996, British Journal of Cancer.

Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays.

N. Raab-Traub, A. Rickinson, Sushmita Roy, 2006, The Journal of infectious diseases.

Epstein-Barr Virus Latency inBloodMononuclear Cells: Analysis ofViral GeneTranscription during Primary Infection andintheCarrier State

S. Young, N. Steven, R. Tierney, 1994 .

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle

M. Rowe, A. Hislop, R. Tierney, 2014, PLoS pathogens.

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

C. Craddock, P. Moss, S. Nagra, 2015, Blood.

Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.

K. Kawa, A. Rickinson, R. Tierney, 2011, The Journal of general virology.

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

A. Strasser, P. Colman, M. Rowe, 2019, Cell Death & Differentiation.

Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Gene Deletion Is Consistently Linked with EBNA3A, -3B, and -3C Expression in Burkitt's Lymphoma Cells and with Increased Resistance to Apoptosis

W. Hammerschmidt, A. Rickinson, R. Tierney, 2005, Journal of Virology.

BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

A. Strasser, O. Kondrashova, G. Lessene, 2020, Blood advances.

The Epstein-Barr Virus BamHI C Promoter Is Not Essential for B Cell Immortalization In Vitro, but It Greatly Enhances B Cell Growth Transformation

M. Rowe, A. Rickinson, R. Tierney, 2014, Journal of Virology.

PCR for the detection of cervical HPV16 infection: The need for standardization

C. Woodman, L. Young, H. Winter, 1993, International journal of cancer.

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

A. Rickinson, R. Tierney, S. Lee, 1997, Journal of immunology.

Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation

A. Rickinson, R. Tierney, A. Bell, 2000, Journal of Virology.

Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA

M. Rowe, R. Tierney, C. Shannon-Lowe, 2015, Virology.

The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5

A. Rickinson, R. Tierney, A. Bell, 2000, Journal of Virology.

The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP / Pax 5

A. Rickinson, R. Tierney, A. Bell, 2000 .

Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and LymphoblastoidCell Lines

A. Rickinson, R. Tierney, G. Kelly, 2006, Journal of Virology.

Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program

W. Hammerschmidt, A. Rickinson, R. Tierney, 2007, Journal of Virology.

Running Title: EBV Wp promoter usage and Wp methylation

A. Rickinson, R. Tierney, G. Kelly, 2006 .

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

A. Strasser, P. Colman, M. Rowe, 2019, Cell Death & Differentiation.

The Epstein-Barr Virus BamHI C Promoter Is Not Essential for B Cell Immortalization In Vitro, but It Greatly Enhances B Cell Growth Transformation

M. Rowe, A. Rickinson, R. Tierney, 2014, Journal of Virology.